Salona Global Medical Device (TSE:EVMT) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Evome Medical Technologies reported a positive financial performance in the third quarter of 2024, achieving $424,000 in adjusted EBITDA and reducing debt by $1.4 million. The company has also expanded its product offerings by launching a new distribution company and appointing Bill Garbarini as the Chief Operating Officer. These strategic moves are part of Evome’s efforts to stabilize its business and strengthen its market position.
For further insights into TSE:EVMT stock, check out TipRanks’ Stock Analysis page.
Trending Articles
- Shareholder Alert for Chipotle Mexican Grill, Inc. (NYSE:CMG)
- 3 Penny Stocks to Watch Now, 11/26/24
- Rivian Gets Conditional DOE Loan of $6.6B for Georgia Plant
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
